CT
MRNA icon

Clearstead Trust’s Moderna MRNA Stock Holding History

Clearstead Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.72K Hold
96
– – ﹤0.01% 712
2026
Q1 		$4.88K Hold
96
– – ﹤0.01% 755
2025
Q4 		$2.83K Sell
96
-78
-45% -$2.12K ﹤0.01% 857
2025
Q3 		$4.5K Buy
174
+162
+1,350% +$4.52K ﹤0.01% 791
2025
Q2 		$332 Sell
12
-108
-90% -$2.84K ﹤0.01% 1406
2025
Q1 		$3.4K Buy
+120
New +$4.26K ﹤0.01% 689
2024
Q4 		– Sell
-10
Closed -$668 – 435
2024
Q3 		$668 Hold
10
– – ﹤0.01% 409
2024
Q2 		$1.19K Hold
10
– – ﹤0.01% 420
2024
Q1 		$1.07K Hold
10
– – ﹤0.01% 416
2023
Q4 		$995 Hold
10
– – ﹤0.01% 402
2023
Q3 		$1.03K Buy
+10
New +$1.11K ﹤0.01% 426

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Clearstead Trust's MRNA Position: Q2 2026 in Review

Clearstead Trust held its Moderna (MRNA) position steady in Q2 2026 at 96 shares worth $6.72K. The position accounts for ﹤0.01% of the portfolio, ranked #712.

Clearstead Trust first reported a position in MRNA in Q3 2023 and has held it in 11 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Clearstead Trust held 96 shares of Moderna worth $6.72K as of Q2 2026.
  • Clearstead Trust left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #712 holding.
  • Clearstead Trust first reported a position in Moderna in Q3 2023 and has held it in 11 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.